# Nuclide record rcc (indication). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/indications/rcc/>
  a schema:MedicalCondition ;
  nuclide:kind "indication" ;
  schema:identifier "rcc" ;
  schema:name "Renal cell carcinoma"@en ;
  schema:alternateName "RCC"@en ;
  schema:description "Kidney cancer is where anti-angiogenic drugs and immunotherapy came together, and where a Nobel-winning oxygen-sensing pathway yielded a drug, belzutifan."@en ;
  schema:url <https://nuclide.cc/indications/rcc/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Renal_cell_carcinoma> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1164529> ;
  schema:citation <https://www.cancer.gov/types/kidney/hp/kidney-treatment-pdq>, <https://www.annalsofoncology.org/article/S0923-7534(24)01516-3/fulltext> ;
  nuclide:tag "gu" ;
  nuclide:related <https://nuclide.cc/collections/src-urotoday/> ;
  nuclide:technologies <https://nuclide.cc/technologies/caix-pet/>, <https://nuclide.cc/technologies/radioimmunotherapy/> ;
  nuclide:companies <https://nuclide.cc/companies/bms/>, <https://nuclide.cc/companies/merck/>, <https://nuclide.cc/companies/pfizer/>, <https://nuclide.cc/companies/novartis/>, <https://nuclide.cc/companies/telix/> ;
  nuclide:institutions <https://nuclide.cc/institutions/mskcc/>, <https://nuclide.cc/institutions/md-anderson/>, <https://nuclide.cc/institutions/dana-farber/> ;
  nuclide:pathways <https://nuclide.cc/pathways/hif-vhl/> ;
  nuclide:terms <https://nuclide.cc/terms/oligometastatic/> ;
  nuclide:trials <https://nuclide.cc/trials/nct07197580/> ;
  nuclide:pipeline <https://nuclide.cc/technologies/caix-pet/>, <https://nuclide.cc/ideas/idea-caix-theranostics/>, <https://nuclide.cc/technologies/radioimmunotherapy/> ;
  nuclide:standardOfCare <https://nuclide.cc/drugs/pembrolizumab/>, <https://nuclide.cc/drugs/pembrolizumab/>, <https://nuclide.cc/drugs/pembrolizumab/>, <https://nuclide.cc/drugs/pembrolizumab/>, <https://nuclide.cc/drugs/cabozantinib/>, <https://nuclide.cc/drugs/pembrolizumab/>, <https://nuclide.cc/drugs/cabozantinib/>, <https://nuclide.cc/drugs/sunitinib/>, <https://nuclide.cc/drugs/cabozantinib/>, <https://nuclide.cc/drugs/everolimus/>, <https://nuclide.cc/drugs/cabozantinib/>, <https://nuclide.cc/drugs/pembrolizumab/> .